By regulating HIF-1 levels, hypoxia affects HIF-1 DNA binding activity and restores ERK pathway activity, resulting in the development of resistance to EGFR inhibitors in BC cells [219, 220]. The gene discussed is EGFR; the disease is breast cancer.